California welfare fund files US antitrust claims against Takeda, Twi over Dexilant
MLex Summary: International Union of Operating Engineers Stationary Engineers Local 39 Health and Welfare Trust Fund filed a US complaint on behalf of end-payers, accusing Takeda Pharmaceutical and Twi Pharmaceuticals of...To view the full article, register now.
Already a subscriber? Click here to view full article